Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PREP Antisense RNA 1 (PREP-AS1) is a long noncoding RNA (lncRNA) identified as an antisense transcript in the human genome. It is catalogued in public gene databases as a member of the antisense RNA and lncRNA families[7]. Like other antisense RNAs, such transcripts often play regulatory roles in gene expression at the level of transcription, splicing, and chromatin interaction[2][3]. However, there is currently no published information regarding PREP-AS1’s specific biological functions, clinical relevance, or disease associations. No evidence has been found supporting its role as a therapeutic target or involvement in drug interaction. The gene designation PREP-AS1 is accurate, but further research is needed to determine its molecular and clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PREP Antisense RNA 1 (PREP-AS1).